Dark

AXSM
Axsome Therapeutics, Inc
stock NASDAQ

At Close

Dec 31, 2025 3:59:57 PM EST

182.73USD+22.811%(+33.94)3,059,410

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 31, 2025 9:27:30 AM EST

158.00USD+6.190%(+9.21)13,503

After-hours

Dec 31, 2025 4:10:30 PM EST

183.50USD+0.421%(+0.77)4,276

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

9.22B

CEO

Herriot Tabuteau

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Feb 17, 2026 (47d)

PDLI PIRS XLV

AXSM Stats

Avg. Vol. 10 Day

760,485

Avg. Vol. 30 Day

587,244

Employees

Market Cap

9,219,463,603

Shares Out.

50,412,640

On/Off Exchange

54%/46%

6 Month Beta

0.38

1 Year Beta

0.66

2 Year Beta

0.67

3 Year Beta

0.71

52 Week Low

79.19

52 Week High

184.40

SMA50

144.32

SMA200

119.69

1 Week

+20.28%

1 Month

+22.71%

3 Month

+54.24%

6 Month

+77.61%

1 Year

+109.44%

2 Year

+137.32%

5 Year

+124.48%

Profile

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.

AXSM Stock Summary

Axsome Therapeutics, Inc (NASDAQ:AXSM) stock price today is $182.73, and today's volume is 3,059,410. AXSM is up 22.811% today. The 30 day average volume is 587,244. AXSM market cap is 9.22B with 50,412,640 shares outstanding.

.dark-mode .Nkp1bZ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Nkp1bZ{ color: #333333; background-color: white; border: 2px solid #333333; }AXSMAxsome Therapeutics, Incstock NASDAQ

AXSM Stock Summary

AXSM
Axsome Therapeutics, Inc
stock NASDAQ